Lyman-Kutcher-Burman NTCP model parameters for radiation pneumonitis and xerostomia based on combined analysis of published clinical data

Physics in Medicine and Biology

Volumn 53, Issue 3, 2008, Pages 737-755

  Semenenko, V A ^a   Li, X A ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXICITY; HOSPITAL DATA PROCESSING; NUCLEAR MEDICINE; PARAMETER ESTIMATION; TISSUE;

LYMAN-KUTCHER-BURMAN (LKB) NTCP MODEL; NORMAL TISSUE COMPLICATION PROBABILITY (NTCP) MODELS; RADIATION PNEUMONITIS;

RADIOTHERAPY;

ARTICLE; CLINICAL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA ANALYSIS; HUMAN; LUNG; LYMAN KUTCHER BURMAN; MODEL; NORMAL TISSUE COMPLICATION PROBABILITY; PAROTID GLAND; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION PNEUMONIA; SALIVATION; SYMPTOM; TREATMENT PLANNING; XEROSTOMIA;

CLINICAL TRIALS AS TOPIC; COMPUTER SIMULATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; MODELS, BIOLOGICAL; RADIATION INJURIES; RADIATION PNEUMONITIS; RADIOTHERAPY; REFERENCE VALUES; RISK ASSESSMENT; RISK FACTORS; UNITED STATES; XEROSTOMIA;

EID: 41849108052     PISSN: 00319155     EISSN: 13616560     Source Type: Journal    
DOI: 10.1088/0031-9155/53/3/014     Document Type: Article

References (67)

1. LENT SOMA 1995 scales for all anatomic sites Int. J. Radiat. Oncol. Biol. Phys. 31 1049-91
2. Belderbos J, Heemsbergen W, Hoogeman M, Pengel K, Rossi M and Lebesque J 2005 Acute esophageal toxicity in non-small cell lung cancer patients after high dose conformal radiotherapy Radiother. Oncol. 75 157-64
3. Blanco A I, Chao K S, El Naqa I, Franklin G E, Zakarian K, Vicic M and Deasy J O 2005 Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy Int. J. Radiat. Oncol. Biol. Phys. 62 1055-69
4. Braam P M, Roesink J M, Moerland M A, Raaijmakers C P, Schipper M and Terhaard C H 2005 Long-term parotid gland function after radiotherapy Int. J. Radiat. Oncol. Biol. Phys. 62 659-64
5. Braam P M, Terhaard C H, Roesink J M and Raaijmakers C P 2006 Intensity-modulated radiotherapy significantly reduces xerostomia compared with conventional radiotherapy Int. J. Radiat. Oncol. Biol. Phys. 66 975-80
6. Burman C, Kutcher G J, Emami B and Goitein M 1991 Fitting of normal tissue tolerance data to an analytic function Int. J. Radiat. Oncol. Biol. Phys. 21 123-35
7. Chang D T, Olivier K R, Morris C G, Liu C, Dempsey J F, Benda R K and Palta J R 2006 The impact of heterogeneity correction on dosimetric parameters that predict for radiation pneumonitis Int. J. Radiat. Oncol. Biol. Phys. 65 125-31
8. Chao K S, Deasy J O, Markman J, Haynie J, Perez C A, Purdy J A and Low D A 2001 A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results Int. J. Radiat. Oncol. Biol. Phys. 49 907-16
9. Cozzi L, Buffa F M and Fogliata A 2000 Comparative analysis of dose volume histogram reduction algorithms for normal tissue complication probability calculations Acta Oncol. 39 165-71
10. Deasy J O 2000 Comments on the use of the Lyman-Kutcher-Burman model to describe tissue response to nonuniform irradiation Int. J. Radiat. Oncol. Biol. Phys. 47 1458-60
11. Eisbruch A, Ten Haken R K, Kim H M, Marsh L H and Ship J A 1999 Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer Int. J. Radiat. Oncol. Biol. Phys. 45 577-87
12. Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider J E, Shank B, Solin L J and Wesson M 1991 Tolerance of normal tissue to therapeutic irradiation Int. J. Radiat. Oncol. Biol. Phys. 21 109-22
13. Fay M, Tan A, Fisher R, Mac Manus M, Wirth A and Ball D 2005 Dose-volume histogram analysis as predictor of radiation pneumonitis in primary lung cancer patients treated with radiotherapy Int. J. Radiat. Oncol. Biol. Phys. 61 1355-63
14. 30 and transforming growth factor β Int. J. Radiat. Oncol. Biol. Phys. 50 899-908
15. Graham M V, Purdy J A, Emami B, Harms W, Bosch W, Lockett M A and Perez C A 1999 Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC) Int. J. Radiat. Oncol. Biol. Phys. 45 323-9
16. Hamilton C S, Chan L Y, McElwain D L and Denham J W 1992 A practical evaluation of five dose-volume histogram reduction algorithms Radiother. Oncol. 24 251-60
17. Hernando M L et al 2001 Radiation-induced pulmonary toxicity: a dose-volume histogram analysis in 201 patients with lung cancer Int. J. Radiat. Oncol. Biol. Phys. 51 650-9
18. Hope A J, Lindsay P E, El Naqa I, Alaly J R, Vicic M, Bradley J D and Deasy J O 2006 Modeling radiation pneumonitis risk with clinical, dosimetric, and spatial parameters Int. J. Radiat. Oncol. Biol. Phys. 65 112-24
19. Jackson A, Kutcher G J and Yorke E D 1993 Probability of radiation-induced complications for normal tissues with parallel architecture subject to non-uniform irradiation Med. Phys. 20 613-25
20. Källman P, Agren A and Brahme A 1992 Tumour and normal tissue responses to fractionated non-uniform dose delivery Int. J. Radiat. Biol. 62 249-62
21. Khan M A, Hill R P and Van Dyk J 1998 Partial volume rat lung irradiation: an evaluation of early DNA damage Int. J. Radiat. Oncol. Biol. Phys. 40 467-76
22. Kim T H et al 2005 Dose-volumetric parameters for predicting severe radiation pneumonitis after three-dimensional conformal radiation therapy for lung cancer Radiology 235 208-15
23. Koh E S, Sun A, Tran T H, Tsang R, Pintilie M, Hodgson D C, Wells W, Heaton R and Gospodarowicz M K 2006 Clinical dose-volume histogram analysis in predicting radiation pneumonitis in Hodgkin's lymphoma Int. J. Radiat. Oncol. Biol. Phys. 66 223-8
24. Konings A W, Cotteleer F, Faber H, van Luijk P, Meertens H and Coppes R P 2005 Volume effects and region-dependent radiosensitivity of the parotid gland Int. J. Radiat. Oncol. Biol. Phys. 62 1090-5
25. Kutcher G J and Burman C 1989 Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method Int. J. Radiat. Oncol. Biol. Phys. 16 1623-30
26. Kwa S L et al 1998 Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients Int. J. Radiat. Oncol. Biol. Phys. 42 1-9
27. Li Y, Taylor J M, Ten Haken R K and Eisbruch A 2007 The impact of dose on parotid salivary recovery in head and neck cancer patients treated with radiation therapy Int. J. Radiat. Oncol. Biol. Phys. 67 660-9
28. Liao Z X, Travis E L and Tucker S L 1995 Damage and morbidity from pneumonitis after irradiation of partial volumes of mouse lung Int. J. Radiat. Oncol. Biol. Phys. 32 1359-70
29. Ling C C and Li X A 2005 Over the next decade the success of radiation treatment planning will be judged by the immediate biological response of tumor cells rather than by surrogate measures such as dose maximization and uniformity Med. Phys. 32 2189-92
30. Lyman J T 1985 Complication probability as assessed from dose-volume histograms Radiat. Res. Suppl. 8 S13-9
31. Lynch B, Cui J, Yang D, Lu W, Hubenschmidt J, Parikh P, Low D, Bradley J, Dempsey J and Deasy J 2007 Four-dimensional dose calculations to determine the effect of breathing motion on outcomes-related parameters for lung cancer patients Int. J. Radiat. Oncol. Biol. Phys. 69 S132-3
32. Martel M K, Ten Haken R K, Hazuka M B, Turrisi A T, Fraass B A and Lichter A S 1994 Dose-volume histogram and 3-D treatment planning evaluation of patients with pneumonitis Int. J. Radiat. Oncol. Biol. Phys. 28 575-81
33. McGinn C J, Ten Haken R K, Ensminger W D, Walker S, Wang S and Lawrence T S 1998 Treatment of intrahepatic cancers with radiation doses based on a normal tissue complication probability model J. Clin. Oncol. 16 2246-52
34. Miften M M, Das S K, Su M and Marks L B 2004 A dose-volume-based tool for evaluating and ranking IMRT treatment plans J. Appl. Clin. Med. Phys. 5 1-14
35. Mohan R, Mageras G S, Baldwin B, Brewster L J, Kutcher G J, Leibel S, Burman C M, Ling C C and Fuks Z 1992 Clinically relevant optimization of 3-D conformal treatments Med. Phys. 19 933-44
36. Moiseenko V, Battista J and Van Dyk J 2000 Normal tissue complication probabilities: dependence on choice of biological model and dose-volume histogram reduction scheme Int. J. Radiat. Oncol. Biol. Phys. 46 983-93
37. Moiseenko V, Craig T, Bezjak A and Van Dyk J 2003 Dose-volume analysis of lung complications in the radiation treatment of malignant thymoma: a retrospective review Radiother. Oncol. 67 265-74
38. Niemierko A and Goitein M 1993 Modeling of normal tissue response to radiation: the critical volume model Int. J. Radiat. Oncol. Biol. Phys. 25 135-45
39. Niemierko A, Urie M and Goitein M 1992 Optimization of 3D radiation therapy with both physical and biological end points and constraints Int. J. Radiat. Oncol. Biol. Phys. 23 99-108
40. Novakova-Jiresova A, van Luijk P, van Goor H, Kampinga H H and Coppes R P 2005 Pulmonary radiation injury: identification of risk factors associated with regional hypersensitivity Cancer Res. 65 3568-76
41. Oetzel D, Schraube P, Hensley F, Sroka-Perez G, Menke M and Flentje M 1995 Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis Int. J. Radiat. Oncol. Biol. Phys. 33 455-60
42. Rancati T, Ceresoli G L, Gagliardi G, Schipani S and Cattaneo G M 2003 Factors predicting radiation pneumonitis in lung cancer patients: a retrospective study Radiother. Oncol. 67 275-83
43. Rancati T, Wennberg B, Lind P, Svane G and Gagliardi G 2007 Early clinical and radiological pulmonary complications following breast cancer radiation therapy: NTCP fit with four different models Radiother. Oncol. 82 308-16
44. Roberts S A and Hendry J H 1993 The delay before onset of accelerated tumour cell repopulation during radiotherapy: a direct maximum-likelihood analysis of a collection of worldwide tumour-control data Radiother. Oncol. 29 69-74
45. Robnett T J, Machtay M, Vines E F, McKenna M G, Algazy K M and McKenna W G 2000 Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer Int. J. Radiat. Oncol. Biol. Phys. 48 89-94
46. Roesink J M, Moerland M A, Battermann J J, Hordijk G J and Terhaard C H 2001 Quantitative dose-volume response analysis of changes in parotid gland function after radiotherapy in the head-and-neck region Int. J. Radiat. Oncol. Biol. Phys. 51 938-46
47. Rosenzweig K E, Fox J L, Yorke E, Amols H, Jackson A, Rusch V, Kris M G, Ling C C and Leibel S A 2005 Results of a phase I dose-escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable nonsmall cell lung carcinoma Cancer 103 2118-27
48. Sanchez-Nieto B and Nahum A E 2000 BIOPLAN: software for the biological evaluation of radiotherapy treatment plans Med. Dosim. 25 71-6
49. Schilstra C and Meertens H 2001 Calculation of the uncertainty in complication probability for various dose-response models, applied to the parotid gland Int. J. Radiat. Oncol. Biol. Phys. 50 147-58
50. Scrimger R A, Stavrev P, Parliament M B, Field C, Thompson H, Stavreva N and Fallone B G 2004 Phenomenologic model describing flow reduction for parotid gland irradiation with intensity-modulated radiotherapy: evidence of significant recovery effect Int. J. Radiat. Oncol. Biol. Phys. 60 178-85
51. Seppenwoolde Y, Lebesque J V, de Jaeger K, Belderbos J S, Boersma L J, Schilstra C, Henning G T, Hayman J A, Martel M K and Ten Haken R K 2003a Comparing different NTCP models that predict the incidence of radiation pneumonitis Int. J. Radiat. Oncol. Biol. Phys. 55 724-35
52. Seppenwoolde Y, De Jaeger K, Boersma L J, Belderbos J S and Lebesque J V 2004 Regional differences in lung radiosensitivity after radiotherapy for non-small-cell lung cancer Int. J. Radiat. Oncol. Biol. Phys. 60 748-58
53. Seppenwoolde Y, De Jaeger K and Lebesque J V 2003b In regard to Tsujino, et al. predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer IJROBP 2003;55:110-115 Int. J. Radiat. Oncol. Biol. Phys. 56 1208-9
54. Song D Y, Benedict S H, Cardinale R M, Chung T D, Chang M G and Schmidt-Ullrich R K 2005 Stereotactic body radiation therapy of lung tumors: preliminary experience using normal tissue complication probability-based dose limits Am. J. Clin. Oncol. 28 591-6
55. Stavrev P, Hristov D, Warkentin B, Sham E, Stavreva N and Fallone B G 2003 Inverse treatment planning by physically constrained minimization of a biological objective function Med. Phys. 30 2948-58
56. Tsougos I et al 2006 Clinical validation of the LKB model and parameter sets for predicting radiation-induced pneumonitis from breast cancer radiotherapy Phys. Med. Biol. 51 L1-9
57. Tsougos I, Nilsson P, Theodorou K, Kjellen E, Ewers S B, Jarlman O, Lind B K, Kappas C and Mavroidis P 2007 NTCP modelling and pulmonary function tests evaluation for the prediction of radiation induced pneumonitis in non-small-cell lung cancer radiotherapy Phys. Med. Biol. 52 1055-73
58. Tsujino K, Hirota S, Endo M, Obayashi K, Kotani Y, Satouchi M, Kado T and Takada Y 2003 Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer Int. J. Radiat. Oncol. Biol. Phys. 55 110-5
59. Wang X H, Mohan R, Jackson A, Leibel S A, Fuks Z and Ling C C 1995 Optimization of intensity-modulated 3D conformal treatment plans based on biological indices Radiother. Oncol. 37 140-52
60. Wang S, Liao Z, Wei X, Liu H H, Tucker S L, Hu C S, Mohan R, Cox J D and Komaki R 2006 Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT) Int. J. Radiat. Oncol. Biol. Phys. 66 1399-407
61. Warkentin B, Stavrev P, Stavreva N, Field C and Fallone B G 2004 A TCP-NTCP estimation module using DVHs and known radiobiological models and parameter sets J. Appl. Clin. Med. Phys. 5 50-63
62. Willner J, Jost A, Baier K and Flentje M 2003 A little to a lot or a lot to a little? An analysis of pneumonitis risk from dose-volume histogram parameters of the lung in patients with lung cancer treated with 3-D conformal radiotherapy Strahlenther. Onkol. 179 548-56
63. Withers H R, Thames H D Jr and Peters L J 1983 A new isoeffect curve for change in dose per fraction Radiother. Oncol. 1 187-91
64. Yamada M, Kudoh S, Hirata K, Nakajima T and Yoshikawa J 1998 Risk factors of pneumonitis following chemoradiotherapy for lung cancer Eur. J. Cancer 34 71-5
65. Yang Y and Xing L 2004 Clinical knowledge-based inverse treatment planning Phys. Med. Biol. 49 5101-17
66. Yorke E D, Jackson A, Rosenzweig K E, Merrick S A, Gabrys D, Venkatraman E S, Burman C M, Leibel S A and Ling C C 2002 Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small-cell lung cancer patients treated with three-dimensional conformal radiation therapy Int. J. Radiat. Oncol. Biol. Phys. 54 329-39
67. Yorke E D, Jackson A, Rosenzweig K E, Braban L, Leibel S A and Ling C C 2005 Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study Int. J. Radiat. Oncol. Biol. Phys. 63 672-82